162 related articles for article (PubMed ID: 38523585)
21. Emerging therapeutics in the management of connective tissue disease. Part I. Lupus erythematosus and Sjögren syndrome.
Skudalski L; Shahriari N; Torre K; Santiago S; Bibb L; Kodomudi V; Grant-Kels JM; Lu J
J Am Acad Dermatol; 2022 Jul; 87(1):1-18. PubMed ID: 35202775
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology of Sjögren syndrome.
Beydon M; McCoy S; Nguyen Y; Sumida T; Mariette X; Seror R
Nat Rev Rheumatol; 2024 Mar; 20(3):158-169. PubMed ID: 38110617
[TBL] [Abstract][Full Text] [Related]
23. Profiles of antinuclear antibodies in systemic rheumatic diseases.
Notman DD; Kurata N; Tan EM
Ann Intern Med; 1975 Oct; 83(4):464-9. PubMed ID: 1080976
[TBL] [Abstract][Full Text] [Related]
24. [Sjögren's syndrome with juvenile onset].
Kaleda MI; Nikishina IP; Latypova AN
Ter Arkh; 2019 May; 91(5):54-60. PubMed ID: 32598677
[TBL] [Abstract][Full Text] [Related]
25. [Clinical characteristics of patients with rheumatic diseases and abnormal liver function].
Wu CY; Li MC; Duan XW; Li HB; Wang YH; Li Q; Luo H; Xu J; Wu LJ; Wang YF; Zhao C; Fang YF; Lin SD; Xu D; Tian XP; Li MT; Zeng XF
Zhonghua Nei Ke Za Zhi; 2023 Sep; 62(9):1102-1113. PubMed ID: 37650184
[No Abstract] [Full Text] [Related]
26. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I.
Helmick CG; Felson DT; Lawrence RC; Gabriel S; Hirsch R; Kwoh CK; Liang MH; Kremers HM; Mayes MD; Merkel PA; Pillemer SR; Reveille JD; Stone JH;
Arthritis Rheum; 2008 Jan; 58(1):15-25. PubMed ID: 18163481
[TBL] [Abstract][Full Text] [Related]
27. EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome.
Drosos GC; Vedder D; Houben E; Boekel L; Atzeni F; Badreh S; Boumpas DT; Brodin N; Bruce IN; González-Gay MÁ; Jacobsen S; Kerekes G; Marchiori F; Mukhtyar C; Ramos-Casals M; Sattar N; Schreiber K; Sciascia S; Svenungsson E; Szekanecz Z; Tausche AK; Tyndall A; van Halm V; Voskuyl A; Macfarlane GJ; Ward MM; Nurmohamed MT; Tektonidou MG
Ann Rheum Dis; 2022 Jun; 81(6):768-779. PubMed ID: 35110331
[TBL] [Abstract][Full Text] [Related]
28. Coexistence of systemic sclerosis, scleroderma-like syndromes and neoplastic diseases.
Ciołkiewicz M; Domysławska I; Ciołkiewicz A; Klimiuk PA; Kuryliszyn-Moskal A
Pol Arch Med Wewn; 2008 Mar; 118(3):119-26. PubMed ID: 18476458
[TBL] [Abstract][Full Text] [Related]
29. Early, Incomplete, or Preclinical Autoimmune Systemic Rheumatic Diseases and Pregnancy Outcome.
Spinillo A; Beneventi F; Locatelli E; Ramoni V; Caporali R; Alpini C; Albonico G; Cavagnoli C; Montecucco C
Arthritis Rheumatol; 2016 Oct; 68(10):2555-62. PubMed ID: 27158919
[TBL] [Abstract][Full Text] [Related]
30. Scleroderma and the Esophagus.
Ahuja NK; Clarke JO
Gastroenterol Clin North Am; 2021 Dec; 50(4):905-918. PubMed ID: 34717878
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
Freites Nuñez DD; Leon L; Mucientes A; Rodriguez-Rodriguez L; Font Urgelles J; Madrid García A; Colomer JI; Jover JA; Fernandez-Gutierrez B; Abasolo L
Ann Rheum Dis; 2020 Nov; 79(11):1393-1399. PubMed ID: 32769150
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis.
Shahane A
Rheumatol Int; 2013 Jul; 33(7):1655-67. PubMed ID: 23334373
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the European League Against Rheumatism/American College of Rheumatology-2019 classification criteria in patients with childhood-onset systemic lupus erythematosus: a single-center retrospective study.
Ohara A; Iwata N; Sugiura S; Abe N; Nakaseko H; Kawabe S
Clin Rheumatol; 2022 Aug; 41(8):2483-2489. PubMed ID: 35377008
[TBL] [Abstract][Full Text] [Related]
34. Spectrum of paediatric rheumatic diseases in Nigeria.
Olaosebikan BH; Adelowo OO; Animashaun BA; Akintayo RO
Pediatr Rheumatol Online J; 2017 Jan; 15(1):7. PubMed ID: 28143550
[TBL] [Abstract][Full Text] [Related]
35. Musculoskeletal Manifestations of Non-RA Connective Tissue Diseases: Scleroderma, Systemic Lupus Erythematosus, Still's Disease, Dermatomyositis/Polymyositis, Sjögren's Syndrome, and Mixed Connective Tissue Disease.
Jacques T; Sudoł-Szopińska I; Larkman N; O'Connor P; Cotten A
Semin Musculoskelet Radiol; 2018 Apr; 22(2):166-179. PubMed ID: 29672805
[TBL] [Abstract][Full Text] [Related]
36. What rheumatologists should know about orofacial manifestations of autoimmune rheumatic diseases.
Abrão AL; Santana CM; Bezerra AC; Amorim RF; Silva MB; Mota LM; Falcão DP
Rev Bras Reumatol Engl Ed; 2016; 56(5):441-450. PubMed ID: 27692394
[TBL] [Abstract][Full Text] [Related]
37. [Rheumatic diseases and allergies, the duality of the immune system].
Sánchez-Zuno GA; Oregón-Romero E; Hernández-Bello J; González-Estevez G; Vargas-Rosales R; Muñoz-Valle JF
Rev Alerg Mex; 2021; 68(4):264-275. PubMed ID: 34904562
[TBL] [Abstract][Full Text] [Related]
38. Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study.
Park EH; Strand V; Oh YJ; Song YW; Lee EB
Arthritis Res Ther; 2019 Feb; 21(1):61. PubMed ID: 30770765
[TBL] [Abstract][Full Text] [Related]
39. Multiparametric autoantibody analysis: a new paradigm for the diagnosis of connective tissue diseases.
Bizzaro N; Villalta D; Bini V; Migliorini P; Franceschini F; Piantoni S; Garrafa E; Riccieri V; Fioravanti A; Bellisai F; Tampoia M; Fornaro M; Iannone F; Ghirardello A; Zen M; Palterer B; Parronchi P; Infantino M; Benucci M; Rigon A; Arcarese L; Del Rosso S; Canti V; Bartoloni E; Gerli R;
Arthritis Res Ther; 2022 Dec; 24(1):278. PubMed ID: 36564813
[TBL] [Abstract][Full Text] [Related]
40. Ocular and eyelid involvement in collagen vascular diseases. Part I. Sjögren syndrome and systemic lupus erythematosus.
Enwereji N; Santiago S; Jiang C; Durrani K; Chaudhry S; Lu J
Clin Dermatol; 2024; 42(1):3-8. PubMed ID: 37858778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]